Publications by authors named "Keisho Kurokawa"
Background/aim: Imeglimin, a novel oral antidiabetic agent, was approved in 2021 for the treatment of type 2 diabetes mellitus (T2DM). Phase III clinical trials demonstrated its safety and efficacy in managing T2DM. However, its safety profile in patients with heart failure has not been thoroughly evaluated in real-world clinical settings.
View Article and Find Full Text PDFArticle Synopsis
- * Epicardial spasms can be categorized into focal (more common in males) and diffuse (more common in females), with different triggers (ACH tends to cause diffuse spasms, while ER triggers focal spasms).
- * Clinical outcomes for patients with focal spasms are usually worse than those with diffuse spasms, but the consistency of these spasm types during testing remains uncertain, as factors like coronary atherosclerosis may influence their occurrence.
: Epicardial spasm (ES) phenotypes may be related to the prognosis in patients with coronary spastic angina. : The purpose of this study was to elucidate the relationship between angiographic coronary vasomotor responses to intracoronary acetylcholine (ACh) injection and prognosis in patients with angina and nonobstructive coronary artery disease (ANOCAD). : This was a retrospective, observational, single-center study of 680 patients with ANOCAD.
View Article and Find Full Text PDF